Lapatinib as second-line treatment after the double block pertuzumab-trastuzumab: a case report
We report the case of a young, 36-year-old patient diagnosed with multifocal breast carcinoma, undergoing neoadjuvant chemotherapy, surgery and adjuvant treatment. The patient presented an early recovery of liver disease after only 7 months of free interval. Histological reevaluation after liver bi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-10-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/131 |